584 
Effect of Antidepressant Medication Treatment on Antiretroviral Adherence and HIV-1 RNA Viral Load in HIV+ Homeless and Marginally Housed Individuals
Alexander Tsai*1, S Weiser2,3, M Petersen2,4, K Ragland3, and D Bangsberg5
1Langley Porter Psychiatric Inst, Univ of California, San Francisco, US; 2Univ of California, San Francisco, US; 3San Francisco Gen Hosp, CA, US; 4Univ of California, Berkeley, US; and 5Massachusetts Gen Hosp, Harvard Med Sch, Harvard Initiative for Global Hlth, Boston, US
Background: Although depression is known to worsen
the course of HIV, less is known about whether antidepressant medication
treatment improves HIV outcomes. Prior studies have inadequately adjusted for
time-varying confounding by indication.
Methods: Participants were selected from a cohort of
HIV+ homeless and marginally housed adults living in San Francisco who had been started on HAART during follow-up. To estimate the effect of
antidepressant treatment on log10 viral load, a marginal structural
model (men who have sex with men [MSM]) was fitted using ordinary least squares
(OLS) regression and weighted by inverse probability-of-treatment-and censoring
weights. The treatment estimate was adjusted for demographic characteristics at
baseline and these time-lagged confounders: substance abuse, homelessness, any
mental health system contact, depression severity, and diagnosis of major
depression. An equivalent MSM was fitted using logistic regression to examine
probability of viral suppression. To determine whether the effect of
antidepressants was mediated by adherence to HAART, 7-day self-reported
adherence was entered into the MSM and the change in the treatment coefficient
re-assessed. A sensitivity analysis used adherence as measured by unannounced
pill counts (available for a subset of participants).
Results: We included 418 participants (1330
person-years of follow-up). Unweighted OLS regression showed a ‑0.56 log10
difference (95%CI, –1.04 to –0.08; p = 0.02) in viral load after
antidepressant treatment, compared to no treatment. Inverse
probability-of-treatment-and censoring-weighting showed a –0.83 log10
difference (95%CI, –1.62 to –0.04; p = 0.04). When 7-day self-reported
adherence was added to the MSM, the estimated log10 viral load
difference was –0.11 (95%CI, –0.92 to 0.71; p = 0.79). Pill count
adherence data were available for 296 participants (258 person-years of
follow-up). When this variable was used in a sensitivity analysis, the
estimated log10 difference was –0.15 (95%CI, –1.07 to 0.77; p =
0.75). Logistic regression showed a non-statistically significant change in the
probability of viral suppression, in both unweighted (OR 1.29; 95%CI 0.96 to 1.74)
and weighted (OR 1.44; 95%CI 0.86 to 2.39) analyses; these estimates were
further reduced in statistical significance by the addition of either adherence
measure to the MSM.
Conclusions: Antidepressant medication treatment
results in a statistically significant reduction in viral load. This effect is
mediated largely through improved adherence to HAART.
|